✦ LIBER ✦

Effect of single ascending, supratherapeutic doses of sparfloxacin on cardiac repolarization (QTc interval)

✍ Scribed by Joel Morganroth; George H. Talbot; Mary B. Dorr; Robert D. Johnson; William Geary; David Magner

Book ID: 117322301
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 705 KB
Volume: 21
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(99)80004-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of a Single Supratherapeutic Dose

Effect of a Single Supratherapeutic Dose of Dolutegravir on Cardiac Repolarization

✍ Shuguang Chen; Sherene S. Min; Amanda Peppercorn; Julie Borland; Yu Lou; Ivy Son 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

A single supratherapeutic dose of ridafo

A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer

✍ Richard M. Lush, Amita Patnaik, Daniel Sullivan… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 273 KB

Effect of single doses of maraviroc on t

Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects

✍ John D. Davis; Frances Hackman; Gary Layton; Tracy Higgins; David Sudworth; Geor 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Evaluation and Management of Cardiac Saf

Evaluation and Management of Cardiac Safety Using the Electrocardiogram in Oncology Clinical Trials: Focus on Cardiac Repolarization (QTc Interval)

✍ Morganroth, J; Shah, R R; Scott, J W 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 181 KB

Prediction and Modeling of Effects on th

Prediction and Modeling of Effects on the QTc Interval for Clinical Safety Margin Assessment, Based on Single-Ascending-Dose Study Data with AZD3839

✍ Sparve, E.; Quartino, A. L.; Luttgen, M.; Tunblad, K.; Gardlund, A. T.; Falting, 📂 Article 📅 2014 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 859 KB

Evaluation of the effect of dapagliflozi

Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study

✍ Glenn F. Carlson; Conrad K. P. Tou; Shamik Parikh; Bruce K. Birmingham; Kathleen 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 362 KB

## Introduction Dapagliflozin is a first-in-class sodium-glucose transporter 2 (SGLT2) inhibitor under investigation for the treatment of type 2 diabetes mellitus. A thorough QTc study was conducted, according to International Conference on Harmonization E14 guidelines, to characterize the effect o